The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
6 pts

Opinion on  Martek Biosciences Corp. (MATK)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Martek Biosciences Corp: Analyst Ratings

Oct 11, 2009 01:47 AM GMT
Return Risk
+2.47% LOW
Associate

Martek Biosciences Corp: Analyst Ratings

Zacks average brokerage recommendation is Moderate Buy .



MATK:  This call was made on 10/11/09 @ $21.48
Rating:   Positive   $21.48 (10/11/09)
Gain/Loss:   -19.13% in 43 days
Target:   $27.01 (+25.74%) in > one year
Allocation:   1.0% of portfolio


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 378
2 Gerald Greene 18.14 +70.10% 208
3 stockmarketfunding.com 17.66 +25.70% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment
BAC Bank of America Corp
DRYS DryShips Inc.
MA MasterCard Inc
XOM Exxon Mobil Corp
C Citigroup Inc
GS Goldman Sachs Group Inc The

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Martek Biosciences Corp. (MATK)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by legan
Symbol SP Sentiment Rating Return Since
AOB Positive -7.58% 11/15/09
CHLN Positive +18.88% 11/11/09
FREE Positive +2.46% 10/22/09
ZIXI Positive -18.57% 10/11/09
AVII Positive -0.64% 10/05/09

View All >
   
legan previously rated MATK
Positive -12.00% Bullish on MATK ...
09/09/2009
0





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch